ALB and systemic lupus erythematosus: Recently, Idborg et al. proposed the use of plasma albumin as a potential biomarker of disease activity in SLE [8], while Yip et al. showed that higher SLEDAI scores correlated with lower serum albumin levels in a large population of patients [9].